Order Article Reprints

Liu Y, Xu T, Vorobyeva A, Loftenius A, Bodenko V, Orlova A, Frejd FY, Tolmachev V. Radionuclide Therapy of HER2-Expressing Xenografts Using [¹⁷⁷Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab. Cancers. 2023; 15(9):2409. https://doi.org/10.3390/cancers15092409

Liu, Yongsheng, Tianqi Xu, Anzhelika Vorobyeva, Annika Loftenius, Vitalina Bodenko, Anna Orlova, Fredrik Y. Frejd, and Vladimir Tolmachev. 2023. "Radionuclide Therapy of HER2-Expressing Xenografts Using [¹⁷⁷Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab" Cancers 15, no. 9: 2409. https://doi.org/10.3390/cancers15092409

Liu, Y., Xu, T., Vorobyeva, A., Loftenius, A., Bodenko, V., Orlova, A., Frejd, F. Y., & Tolmachev, V. (2023). Radionuclide Therapy of HER2-Expressing Xenografts Using [¹⁷⁷Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab. Cancers, 15(9), 2409. https://doi.org/10.3390/cancers15092409